LAST PRICE - AT THE CLOSE
DRUG is DOWN -10% since the begininning of the year
DRUG is DOWN -7% BELOW 20 day SMA
DRUG is UP 20% ABOVE 200 day SMA
PROFITABLE: NO
EPS: $-0.536582
EARNINGS MOMENTUM: YES
0.14% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 43.4% AWAY FROM ALL-TIME HIGHS OF $123.75 |
 |
DRUG IS DOWN -10% SINCE THE BEGINNING OF THE YEAR |
 |
DRUG IS UP 94% OVER THE PAST 12 MONTHS |
 |
DRUG IS DOWN -18% OVER THE PAST 1 MONTH |
 |
6% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
 |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | New premarket high. ... | 03/27 |
 | Down 5% for the day. | 03/27 |
 | Currently at 1 x ave... | 03/27 |
 | Crossed above VWAP | 03/27 |
 | Crossed below VWAP | 03/27 |
 |
DRUG moved up 0 in the previous minute |
 |
DRUG is up 0.21 over the last hour |
 |
DRUG is up 3.1% over the last 5 days |
 |
DRUG is 3.1 above its 8 day SMA |
| $69.41 |   DAY |
$74.65 |
| $72.05 | PREVIOUS DAY |
$74.72 |
| $69.60 | WEEK |
$77.01 |
| $69.01 | MONTH |
$86.12 |
| $0.94 |  YEAR |
$123.75 |
DRUG is mentioned N/A less than normal on 
DRUG is mentioned N/A times in an average day on 
